REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/26/2025
Back to search
Official data from USPTO
ETHICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ETHICA
ST13
US500000078277322Class
35, 41, 42
Filing
78277322
Registration
3188634
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
12/27/2025
Trademark type
Word
Nice classes
35, 41, 42
Filing date
07/22/2003
Registration date
12/26/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/23/2017
Last transaction
12/27/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
09/01/2002
First use in commerce
09/01/2002
Drawing code
1
Owner type
03
Owner location
KIRKLAND, QUEBEC, CA
Examiner
ANKRAH,NAAKWAMA S
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ETHICA CRO INC.
Ethica Clinical Research Inc.
Ethica Clinical Research Inc.
Representatives
Dan S. Cohn HUSCH BLACKWELL LLP
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Clinical trial supplies management servicesnamely-customized drug packaging and labelingcentral and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical suppliesnamely study drugs and devicescase report formsstudy binders and all study related documentation; clinical trial management servicesnamely-pre-study document collection and reviewsite selectionpre-study site visitsinitiation visitsmonitoring visitsclose-out visitsproject tracking and monitoring reportsnegotiation and administration of investigator grantslabelingpackagingdistributioncoordination and tracking of clinical trial materialsregulatory document processingcentral laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programsnamely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materialsnamely study protocolsamendmentspaper and electronic case report formsinformed consent forms; managing study operations/monitoring manuals in accordance with data management conventionsweb-based data listingsnamely adverse eventsenrollment statusefficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollmentessential documentsmonitoringsubject and case report form trackingdrug accountabilitydata queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trialsnamely managing investigatorstechniciansparticipantsethical reviewsinvestigator meetingsdatabasesstatistical analyses and reportingrandomization logisticsmedical writing services; recruitment of investigatorstechnicians and participants; providing strategies for recruitment of participants
Class 41
Study specific clinical personnel training programs for investigatorscoordinators and investigator meetings; conducting investigator meetings
Class 42
Research services for clinical trials for othersnamely conducting an ethical review of projects to protect the rights and welfare of research participantsdeveloping study protocolsdesigning case report formsdeveloping participant screening toolsnamely general and medical questionnairesdeveloping complete databases in accordance with strict guidelinestracking of study parametersproviding statistical analysesreporting and developing tracking tools for enrollmentessential documentsmonitoringsubject and case report form trackingdrug accountabilitydata queries and adverse events; developing and implementing randomization logisticsnamely randomization envelopescustomized blind-breakable drug labelingcode break management and reportsmanufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing servicesnamely-drafting clinical study protocolsamendmentscase report formsinformed consent formsstatistical analysis plansfull integrated clinical research reportspublicationsabstracts and manuscript; developing site and study-specific subject recruitment strategies and programsnamely contingency strategies and solutions to address specific project challenges; developing study operations and monitoring manuals in accordance with data management conventionsweb-based data listingsnamely adverse eventsenrollment statusefficacy endpoints and paper and electronic study newsletters
Publications
History of USPTO decisions and trademark events.
57 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/20/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/23/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/23/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/23/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
12/22/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/26/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/16/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/15/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/15/2013
E815
TEAS SECTION 8 & 15 RECEIVED
12/20/2012
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/23/2009
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/23/2009
EXPT
EXPARTE APPEAL TERMINATED
01/29/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
12/26/2006
PUBO
PUBLISHED FOR OPPOSITION
10/10/2006
NPUB
NOTICE OF PUBLICATION
09/20/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/18/2006
ALIE
ASSIGNED TO LIE
08/11/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2006
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/15/2006
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/15/2006
GECD
ACTION DENYING REQ FOR RECON E-MAILED
02/15/2006
CNCF
ACTION CONTINUING FINAL - COMPLETED
02/15/2006
EXPI
EX PARTE APPEAL-INSTITUTED
12/28/2005
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/28/2005
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
12/22/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/13/2005
GNFR
FINAL REFUSAL E-MAILED
06/13/2005
CNFR
FINAL REFUSAL WRITTEN
06/13/2005
IUAA
USE AMENDMENT ACCEPTED
05/20/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/18/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2005
FAXX
FAX RECEIVED
04/29/2005
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/11/2005
CNSI
SUSPENSION INQUIRY WRITTEN
04/11/2005
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/10/2005
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2004
CNSL
SUSPENSION LETTER WRITTEN
09/09/2004
ACEC
AMENDMENT FROM APPLICANT ENTERED
08/12/2004
ALIE
ASSIGNED TO LIE
08/12/2004
ACEC
AMENDMENT FROM APPLICANT ENTERED
08/09/2004
ALIE
ASSIGNED TO LIE
08/09/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2004
PAPER RECEIVED
07/30/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2004
GNRT
NON-FINAL ACTION E-MAILED
01/27/2004
DOCK
ASSIGNED TO EXAMINER
01/12/2004
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/17/2003
IUAF
USE AMENDMENT FILED
09/10/2003
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/10/2003
Continuous trademark protection
Get notified about every new filing that threatens ETHICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.